Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46.1M
-
Number of holders
-
171
-
Total 13F shares, excl. options
-
59.6M
-
Shares change
-
+1.69M
-
Total reported value, excl. options
-
$2.37B
-
Value change
-
+$56.5M
-
Put/Call ratio
-
0.41
-
Number of buys
-
85
-
Number of sells
-
-88
-
Price
-
$39.73
Significant Holders of Apogee Therapeutics, Inc. - Common Stock (APGE) as of Q3 2025
219 filings reported holding APGE - Apogee Therapeutics, Inc. - Common Stock as of Q3 2025.
Apogee Therapeutics, Inc. - Common Stock (APGE) has 171 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 59.6M shares
.
Largest 10 shareholders include VR ADVISER, LLC (8.49M shares), FMR LLC (6.92M shares), WELLINGTON MANAGEMENT GROUP LLP (4.72M shares), RTW INVESTMENTS, LP (2.71M shares), BlackRock, Inc. (2.69M shares), VANGUARD GROUP INC (2.25M shares), Driehaus Capital Management LLC (2.16M shares), Fairmount Funds Management LLC (2.05M shares), STATE STREET CORP (1.66M shares), and Paradigm Biocapital Advisors LP (1.52M shares).
This table shows the top 171 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.